The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trial, J.
Right arrow Articles by Rossen, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trial, J.
Right arrow Articles by Rossen, R. D.
The Journal of Immunology, 2004, 173: 2190-2198.
Copyright © 2004 by The American Association of Immunologists

Monocyte Activation by Circulating Fibronectin Fragments in HIV-1-Infected Patients1

JoAnn Trial*,{dagger}, Jose A. Rubio*,{dagger}, Holly H. Birdsall*,{ddagger},§, Maria Rodriguez-Barradas{dagger} and Roger D. Rossen2,*,{dagger},§

* Research Center for AIDS and HIV Infections, Immunology Research Laboratory, Veterans Affairs Medical Center, Houston, TX 77030 and Departments of {dagger} Medicine, {ddagger} Otorhinolaryngology, and § Immunology, Baylor College of Medicine, Houston, TX 77030

To identify signals that can alter leukocyte function in patients receiving highly active antiretroviral therapy (HAART), we analyzed single blood samples from 74 HIV-1-infected patients and additional blood was collected at 90-day intervals from 51 HIV-1-infected patients over a 516 ± 172 (mean ± SD) day interval. Despite the absence of circulating immune complexes and normalization of phagocytic function, compared with controls, the fraction of patients’ monocytes expressing CD49e and CD62L was decreased and expression of CD11b and CD86 increased. Plasma from 63% of patients but none from normal controls contained 110–120 kDa fibronectin fragments (FNf). Presence of FNf did not reflect poor adherence to therapy. Addition of FNf to normal donor blood in vitro replicated changes in monocyte CD49e, CD62L, CD11b, and CD86 seen in vivo. FNf also induced monocytes to release a serine proteinase, nominally identified as proteinase-3, that hydrolyzed cell surface CD49e. {alpha}1-Antitrypsin blocked FNf-induced shedding of CD49e in a dose-dependent manner. Plasma with a normal frequency of CD49e+ monocytes contained antiproteases that partially blocked FNf-induced monocyte CD49e shedding, whereas plasma from patients with a low frequency of CD49e+ monocytes did not block this effect of FNf. Electrophoretic analyses of plasma from the latter group of patients suggested that a significant fraction of their {alpha}1-antitrypsin was tied up in high molecular mass complexes. These results suggest that monocyte behavior in HIV-1-infected patients may be influenced by FNf and the ratio of protease and antiproteases in the cells’ microenvironment.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. H. Birdsall, W. J. Porter, J. Trial, and R. D. Rossen
Monocytes Stimulated by 110-kDa Fibronectin Fragments Suppress Proliferation of Anti-CD3-Activated T Cells
J. Immunol., September 1, 2005; 175(5): 3347 - 3353.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. H. Birdsall, W. J. Porter, D. M. Green, J. Rubio, J. Trial, and R. D. Rossen
Impact of Fibronectin Fragments on the Transendothelial Migration of HIV-Infected Leukocytes and the Development of Subendothelial Foci of Infectious Leukocytes
J. Immunol., August 15, 2004; 173(4): 2746 - 2754.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.